摘要
目的构建CXCL10-pcDNA3.1(+)重组质粒及稳定转染乳腺癌细胞系MCF-7细胞株,探讨CXCL10对MCF-7细胞株肿瘤相关基因表达的影响。方法从1干扰素(IFN-1)刺激的人外周血单个核细胞中克隆CXCL10基因,构建CXCL10-pcDNA3.1(+)重组质粒,用CXCL10-pcDNA3.1(+)和对照质粒pcDNA3.1(+)分别以脂质体转染MCF-7细胞株,经G418筛选后获得稳定转染细胞株,以逆转录(RT)-PCR鉴定CXCL10基因表达,免疫印迹(WB)及ELISA鉴定CXCL10蛋白表达及分泌。以琼脂克隆形成实验分别计算实验组[转染CXCL10-pcDNA3.1(+)的MCF-7细胞株]、对照组[pcDNA3.1(+)的MCF-7细胞株]及未转染组(未转染的MCF-7细胞株)的细胞增殖活性;RT—PCR鉴定肿瘤相关基因基质金属蛋白酶9(MMP9)、血管内皮细胞生长因子(VEGF)及信号转导和转录激活因子3(STAT3)在各细胞株中的表达。结果重组质粒CXCL10-pcDNA3.1(+)及质粒pcDNA3.1(+)稳定转染MCF-7细胞株构建成功;克隆形成率在实验组、对照组及未转染组分别为78.2%、79.9%及87.8%,3组间比较差异无统计学意义(χ2=3.8,P〉0.05);实验组细胞能高效表达CXCL10mRNA,3组间比较差异有统计学意义(F=50.5,P〈0.01);ELISA结果显示细胞培养上清液中CXCL10的表达量3组间比较,差异有统计学意义(F=54.8,P〈0.01);MMP9基因转录水平在实验组、对照组及未转染组分别为0.067±0.003、0.103±0.007及0.085±0.026,均很低,且组间差异无统计学意义(F=4.2,P〉0.05);VEGF在实验组、对照组及未转染组灰度值分别为0.183±0.003、0.787±0.019及0.789±0.011,3组间比较差异有统计学意义(F=2232,P〈0.01);STAT3在实验组、对照组及未转染组灰度值分别为0.573±0.016、0.707±0.008及0.711±0.013,3组间比较差异有统计学意义(F=115,P〈0.01)。结论CXCL10能在MCF-7细胞株稳定表达,且CXCL10能抑制MCF-7细胞VEGF及STAT3表达,从而发挥抗肿瘤作用。
Objective To construct stable transfected MCF-7 cell line by recombinant plasmid CXCL10-pcDNA3.1 ( + ) and explore the effects of CXCL10 on expression of tumor related genes. Methods CXCL10 gene, cloned from treated PBMCs by IFN-5,,was used to construct recombinant plasmid CXCL10- peDNA3.1 ( + ). Recombinant plasmid CXCL10-pcDNA3.1 ( + ) and control plasmid pcDNA3.1 (+ ) were separately transfeeted into MCF-7 cells by lipifeetion-2000. The stable transfected cell lines were screened by G418. The transcription, expression and secretion of transfected CXCL10 gene was assayed by RT-PCR, Western blot and ELISA in turn. The cell growth activity of stable transfected cell lines was detected by soft agar cloning formation in experimental group [ transfected by CXCL10-pcDNA 3. 1 ( + ) ] , control group [transfected by pcDNA3.1 ( + )] and blank group (nothing transfected). Furthermore, the reverse transcriptions of three tumor related genes, included MMP9, VEGF and STAT3, were assayed by RT-PCR. Results The stable MCF-7 cell lines transfected by combined plasmid CXCL10-pcDNA3. 1 ( + ) and plasmid pcDNA3.1 ( + ) were constructed successfully. There was no significant difference in cell growth activity rate between the experimental group and the control group (χ2 = 3. 8, P 〉 0. 05, the rates of the 3 groups were 78.2% ,79.9% and 87.8% in turn). There was significant difference in CXCL10 mRNA expression level between the experimental group and the control group ( F = 50. 5, P 〈 0. 01 ). The ELISA result showed that CXCL10 had significant difference between the experimental group and the control group ( F = 54. 8,P 〈 0.01 ). MMP9, showed stable low expression level in the 3 groups simutaneously ( F = 4. 2, P〉0.05, the gray values of the 3 groups were seperately 0.067 ±0.003, 0. 103 ±0.007 and 0.085 ± 0. 026). Comparing with the control group, the experimental group showed significant lower expression level of VEGF (F=2 232,P 〈0. 01, the gray values of the 3 groups were 0. 183 ±0. 003, 0. 787 ±0. 019 and 0.789±0.011) and STAT3 (F=II5,P〈0.01, the gray values of the 3 groups were 0.573 ±0.016, 0. 707± 0. 008 and 0. 711 ± 0. 013 ). Conclusions CXCL10 can express stablely in MCF-7 cell lines, which resulted in down-regulation of expression of VEGF and STAT3 gene. CXCL10 played an important role in anti-tumor effect.
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2009年第9期1059-1063,共5页
Chinese Journal of Laboratory Medicine
基金
浙江省医药卫生科技计划资助项目(2005A108)